Inhibition of cyclophosphamide mutagenicity by β-carotene

M. A. Belisario, R. Pecce, C. Battista, N. Panza, G. Pacilio

Research output: Contribution to journalArticlepeer-review


Cyclophosphamide (CP) metabolites, rather than the parent compound, show mutagenic activity towards Salmonella typhimurium TA 1535 tester strain when S9 fraction from phenobarbital (PB)-induced rat liver is used as in vitro metabolizing system. On the other hand, inhibition of CP in vitro mutagenicity was observed by adding increasing amounts of β-carotene (β-C) to the system. A typical dose-dependent mutagenic response was observed by assaying 24 h urine samples of PB-induced rats injected i.p. with different amounts of CP. Addition of β-C to urines of CP-treated rats failed to inhibit their mutagenicity. Conversely, a marked decrease in urine mutagenicity was observed when rats were simultaneously treated with the two drugs. These data show that β-carotene partially inhibits, in vitro and in vivo, CP metabolism via hepatic mixed-function oxidase enzymes to mutagenic species.

Original languageEnglish
Pages (from-to)445-448
Number of pages4
JournalBiomedicine and Pharmacotherapy
Issue number8
Publication statusPublished - 1985

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Inhibition of cyclophosphamide mutagenicity by β-carotene'. Together they form a unique fingerprint.

Cite this